UNIGE document Scientific Article
previous document  unige:45951  next document
add to browser collection
Title

Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial
Authors
Finckh, Axel
Mc Carthy, Geraldine M
Madigan, Anne
Van Linthoudt, Daniel
Weber, Marcel
Neto, David
Rappoport, Georges
Blumhardt, Sandra
show hidden authors show all authors [1 - 10]
Published in Arthritis Research and Therapy. 2014, vol. 16, no. 5, p. 458
Abstract Calcium pyrophosphate deposition (CPPD) may cause severe arthropathy, major joint destruction and treatment options are limited. The aim of this study was to test the therapeutic efficacy of methotrexate (MTX) in chronic or recurrent CPPD arthropathy.
Identifiers
PMID: 25315665
Full text
Article (Published version) (558 Kb) - public document Free access
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format) 		FINCKH, Axel et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. In: Arthritis Research and Therapy, 2014, vol. 16, n° 5, p. 458. https://archive-ouverte.unige.ch/unige:45951

292 hits

13 downloads

Contact an author

Update request

Update

Deposited on : 2015-01-28

Export document
Format :
Citation style :